Trial to Assess Chelation Therapy 2 (TACT2) is a randomized, double blind controlled
factorial clinical trial of edetate disodium-based chelation and high-dose oral vitamins and
minerals to prevent recurrent cardiac events in diabetic patients with a prior myocardial
infarction (MI).
Phase:
Phase 3
Details
Lead Sponsor:
Mt. Sinai Medical Center, Miami
Collaborators:
Duke Clinical Research Institute National Center for Complementary and Integrative Health (NCCIH) National Heart, Lung, and Blood Institute (NHLBI)